RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Formosa Laboratories Stock

Formosa Laboratories EBIT 2024

Formosa Laboratories EBIT

961.86 M TWD

Ticker

4746.TW

ISIN

TW0004746003

In 2024, Formosa Laboratories's EBIT was 961.86 M TWD, a 42.5% increase from the 674.98 M TWD EBIT recorded in the previous year.

The Formosa Laboratories EBIT history

YEAREBIT (undefined TWD)
2025e1.24
2024e0.96
20230.67
20220.16
2021-0.17
20200.03
20190.02
20180.06
20170.38
20160.66
20150.33
20140.27
2013-0.08
20120.04
20110.24
20100.32
20090.25
20080.22
20070.15
20060.13

Formosa Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Formosa Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Formosa Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Formosa Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Formosa Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Formosa Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Formosa Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Formosa Laboratories’s growth potential.

Formosa Laboratories Revenue, EBIT and net profit per share

DateFormosa Laboratories RevenueFormosa Laboratories EBITFormosa Laboratories Net Income
2025e5.81 B TWD1.24 B TWD1.11 B TWD
2024e5.09 B TWD961.86 M TWD632.32 M TWD
20234.36 B TWD674.98 M TWD126.24 M TWD
20223.77 B TWD163.49 M TWD409.36 M TWD
20213.14 B TWD-168.02 M TWD1.25 B TWD
20203.08 B TWD28.01 M TWD400.03 M TWD
20192.76 B TWD24.44 M TWD11.63 M TWD
20182.69 B TWD60.48 M TWD176.82 M TWD
20172.54 B TWD378.2 M TWD238.65 M TWD
20163.19 B TWD663.42 M TWD483.44 M TWD
20152.6 B TWD325.57 M TWD282.39 M TWD
20142.5 B TWD273.95 M TWD262.5 M TWD
20132.47 B TWD-75 M TWD-69.4 M TWD
20122.52 B TWD37 M TWD5 M TWD
20112.63 B TWD243.9 M TWD231.1 M TWD
20102.51 B TWD321.3 M TWD246.6 M TWD
20091.9 B TWD252.8 M TWD225.9 M TWD
20082.04 B TWD220.6 M TWD219.1 M TWD
20071.71 B TWD154.7 M TWD142.4 M TWD
20061.36 B TWD134.6 M TWD110.1 M TWD

Formosa Laboratories stock margins

The Formosa Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Formosa Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Formosa Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Formosa Laboratories's sales revenue. A higher gross margin percentage indicates that the Formosa Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Formosa Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Formosa Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Formosa Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Formosa Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Formosa Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Formosa Laboratories Margin History

Formosa Laboratories Gross marginFormosa Laboratories Profit marginFormosa Laboratories EBIT marginFormosa Laboratories Profit margin
2025e44.11 %21.38 %19.14 %
2024e44.11 %18.88 %12.41 %
202344.11 %15.48 %2.9 %
202236.92 %4.34 %10.87 %
202130.91 %-5.35 %39.75 %
202030.73 %0.91 %13.01 %
201929.91 %0.89 %0.42 %
201834.01 %2.25 %6.58 %
201739.61 %14.89 %9.4 %
201639.43 %20.8 %15.16 %
201531.04 %12.54 %10.87 %
201427.51 %10.97 %10.52 %
201313.72 %-3.03 %-2.81 %
201215.5 %1.47 %0.2 %
201122.29 %9.29 %8.8 %
201023.86 %12.82 %9.84 %
200925.33 %13.32 %11.9 %
200818.55 %10.79 %10.72 %
200713.18 %9.05 %8.33 %
200614.33 %9.91 %8.1 %

Formosa Laboratories Aktienanalyse

What does Formosa Laboratories do?

Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Formosa Laboratories's EBIT

Formosa Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Formosa Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Formosa Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Formosa Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Formosa Laboratories stock

How much did Formosa Laboratories achieve in EBIT for the current year?

In the current year, Formosa Laboratories has achieved an EBIT of 961.86 M TWD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Formosa Laboratories.

How has the EBIT of Formosa Laboratories developed in recent years?

The EBIT of Formosa Laboratories has increased by 42.503% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Formosa Laboratories?

The EBIT of Formosa Laboratories is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Formosa Laboratories pay?

Over the past 12 months, Formosa Laboratories paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Formosa Laboratories is expected to pay a dividend of 0.99 TWD.

What is the dividend yield of Formosa Laboratories?

The current dividend yield of Formosa Laboratories is 1.01 %.

When does Formosa Laboratories pay dividends?

Formosa Laboratories pays a quarterly dividend. This is distributed in the months of September, August, September, September.

How secure is the dividend of Formosa Laboratories?

Formosa Laboratories paid dividends every year for the past 4 years.

What is the dividend of Formosa Laboratories?

For the upcoming 12 months, dividends amounting to 0.99 TWD are expected. This corresponds to a dividend yield of 1 %.

In which sector is Formosa Laboratories located?

Formosa Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Formosa Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Formosa Laboratories from 9/12/2024 amounting to 2 TWD, you needed to have the stock in your portfolio before the ex-date on 8/13/2024.

When did Formosa Laboratories pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Formosa Laboratories in the year 2023?

In the year 2023, Formosa Laboratories distributed 2 TWD as dividends.

In which currency does Formosa Laboratories pay out the dividend?

The dividends of Formosa Laboratories are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Formosa Laboratories

Our stock analysis for Formosa Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Formosa Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.